Global Transplantation Market by Application Type (Tissue Transplant, Organ), by Product Type (Tissue Products, Immunosuppressive Drugs) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

Summary of the Report

Global transplantation market value was USD 8.4 billion in 2020. It is projected to grow at a compound annual rate (CAGR), of 11.5% during the forecast period. The market's growth is due to the increasing demand for new tissue transplantation products as well as organ transplantation in the treatment of organ disease. Organ failure can be caused by many factors such as severe trauma, loss, blood poisoning, drug abuse, leukemia and sepsis. End-stage renal disease is most commonly caused by diabetes or high blood pressure. Dialysis and kidney transplant are the only options for keeping a patient alive. Globally, there is a high demand for organ and tissue transplantation. The U.S. Department of Health & Human Services estimates that there were approximately 122,913 Americans waiting for organ transplants in 2019. Organ failure can also be caused by unhealthy eating habits, excessive alcohol consumption, and inactivity.

Market growth is also being boosted by the introduction of new products and an increase in tissue banks. The market growth will be slowed by certain factors such as a shortage of organ donors to perform transplantation procedures. The large gap between demand and supply for organs in organ failure treatment is due to many religious and customary beliefs as well as a lack of awareness about organ donation.

The U.S. Department of Health & Human Services estimates that there were approximately 43,201 people waiting to receive kidney transplants in 2019. Only 23,401 kidney transplants were performed. The recipients of transplantation surgery are also prescribed immunosuppressive medications. This increases their vulnerability to infectious diseases and weakens their immunity.

Impact of COVID19: Market fell by 50% in 2020

This could impact the demand for transplantation services in many countries during the global COVID-19 epidemic. The sharp drop in market revenue for 2020 has been due to a lack of resources such as ICU and primary protective equipment.

Product Type Insights

Tissue products accounted for over 57% of the market and was the highest-generating segment in terms of revenue in 2020. Tissue products, immunosuppressants and preservation solutions are the most important products for organ or tissue transplant. This segment is growing due to the increasing demand for transplantation procedures such as heart valves, cochlear, bone marrow and orthopedic soft tissue. The market is also being driven by new product development. Arthrex Inc., for example, launched ArthroFlex Acellular Dermal Matrix in September 2015. This new orthobiologic product is designed to be used in capsular reconstruction. This product allows the retention of its growth factors, native collagen scaffold, and elastin. It also allows for transplant to be successful incorporated into receivers.

Manufacturers are now focusing on product development, mergers and acquisitions, as well as collaborations, to increase their product portfolio and strengthen their market position. Stryker Corporation purchased Instratek in September 2016. Instratek is a leader manufacturer of soft tissue recession instruments that are minimally invasive for the foot, ankle, and upper extremities.

In the forecast period, the segment of immunosuppressive drugs is expected to show the fastest CAGR. This is due to the high use of these drugs to prevent organ rejection or tissue loss after transplantation. An increase in chronic diseases has resulted in a greater demand for organ replacements. Accordingly, the demand for immunosuppressive medications is forecast to rise at a rapid pace over the forecast period.

Due to the government's support for stem cell research, and the wide range of applications of these products to improve organ function, the preservation solutions segment will experience significant growth over the course of the study period. The segment is expected to grow due to increasing organ failure cases and increased demand for transplant procedures.

Application Type Insights

The global transplantation market was led by tissue transplantation with a 61% share in 2020. This segment is expected to grow at the fastest CAGR between 2021 and 2028. The most common procedures are skin, cornea, bone, nerves and heart valve replacements. Tissue products will be in high demand due to the increasing number of accident and burn cases. According to the European Road Safety Observatory report there were 102,362 cases of accidental injuries in Spain. This has created a demand for tissue donation.

The segment of organ transplantation is expected to grow at 10.8% over the forecast period. The market is expected to grow due to an increase in organ transplantations worldwide and the repeated purchase of immunosuppressants. In 2017, for example, there were approximately 90,306 kidney transplants performed globally.

The number of transplant procedures will increase due to technological advances in transplantation and new products being launched by manufacturers. This is especially true for organs such as the liver, kidney, heart, lung, and other tissues. Lupin, for example, announced in November 2020 that it had launched Tacrolimus, a generic immunosuppressant drug, on the U.S. Market. This is indicated to prophylaxis against organ rejection in allogeneic kidney, heart, and liver transplants.

A high number of transplants was reported in the U.S. and U.K. in 2020. This number is expected to grow in the future. These countries have a well-developed healthcare system and are home to skilled surgeons and advanced products.

End-use Insights

In 2020, the hospital segment accounted for 49% of all revenue. Hospitals are the primary treatment center for many organ and tissue transplant procedures. Segment growth will also be fueled by the development of hospitals with a well-developed infrastructure. These hospitals are able to access well-designed databases that allow them to verify the availability of organs to aid in quick medical intervention.

The highest expected CAGR for the transplant centers segment over the forecast period is expected to be 4.06%. The need for modern healthcare facilities has increased due to the rising demand for transplantation procedures. The segment is expected to grow due to rising government efforts to encourage organ donation. The Health Resources and Services Administration's Division of Transplantation sponsored four grants programs that aimed to increase the number of organ donors and improve transplant procedures.

There are many advanced transplant centers and established healthcare infrastructure in the U.S., France and the U.K. which will increase the demand for these products. According to the National Kidney Center there are approximately 244 U.S. kidney transplant centers. The segment will also grow in emerging countries due to the rising number of organ donors and the growing burden of chronic and acute diseases like high blood pressure and diabetes.

Regional Insights

North America dominated the global market for 2020, with a 39% share. It is expected to continue its dominance during the study period. Market growth is supported by the presence of large-scale medical device and biotechnology companies in the region, including Arthrex, Inc., Zimmer Biomet, Medtronic, Novartis AG, Stryker, and Medtronic.

In the past decade, there has been an increase in the gap between supply and demand for organs such as kidney, liver and heart. Governments and non-governmental organizations from different countries have taken steps to encourage organ donation and save lives. The donation process is now more transparent thanks to new rules and guidelines. In April 2020, the Human Resource & Services Administration launched the Hospital Organ Donor Campaign. This campaign resulted in an increase of organ donations compared to the previous year.

Asia Pacific is expected to be the fastest growing regional market over the forecast period. This is due to extensive research into stem cells and the development of in vitro tissue and organs, as well as improvements in healthcare infrastructure in countries like India, Thailand and Indonesia.

Market Share Insights & Key Companies

With many small- and large-scale vendors, the market is fragmented. Major players are involved with new product launches, mergers and acquisitions, as well as regional expansion, in order to maximize their revenue share. Vendors can expand their product range and geographic reach through acquisitions and mergers. To strengthen its product range and distribution channels, AbbVie bought Allergan in May 2020.

There is a high demand for transplant products due to rising regulatory approvals for allografts and autologous grafts and other materials, as well as the development of innovative products such 3D bioprinting for tissue regeneration and organ regeneration. In September 2020, CollPlant Biotechnologies, an Israeli company, and United Therapeutics announced a partnership to include 3D Bioprinting in human kidney development for transplant. The following are some of the most prominent players in the global market for transplantation:

• Stryker Corp.

• Medtronic PLC

• AbbVie Inc.

• Zimmer Biomet

• Novartis International AG

• 21st Century Medicine

• Biolife Solutions

• Teva Pharmaceutical

• Veloxis Pharmaceuticals

Up Market Research published a new report titled “Transplantation Market research report which is segmented by Application Type (Tissue Transplant, Organ), by Product Type (Tissue Products, Immunosuppressive Drugs), By Players/Companies Teva Pharmaceutical, Zimmer Biomet, 21st Century Medicine, AbbVie Inc, Medtronic PLC, Stryker Corp, Veloxis Pharmaceuticals, Novartis International AG, Biolife Solutions”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

Report Scope

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global Transplantation Market Report Segments:

The market is segmented by Application Type (Tissue Transplant, Organ), by Product Type (Tissue Products, Immunosuppressive Drugs).

Transplantation Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Transplantation Market

Overview of the regional outlook of the Transplantation Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Highlights of The Transplantation Market Report:

1. The market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends of Transplantation Market.
3. Historical data and forecast.
4. Estimations for the forecast period 2028.
5. Developments and trends in the market.

                1. Tissue Transplant

                2. Organ

                1. Tissue Products

                2. Immunosuppressive Drugs

8. Market scenario by region, sub-region, and country.
9. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
10. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
11. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Transplantation Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

• Correctly Positioning New Products
• Market Entry Strategies
• Business Expansion Strategies
• Consumer Insights
• Understanding Competition Scenario
• Product & Brand Management
• Channel & Customer Management
• Identifying Appropriate Advertising Appeals

Reasons to Purchase the Transplantation Market Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
• Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
• Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
• Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.